Christian Marsolais
![Christian Marsolais Christian Marsolais](https://adc-toxicity.com/wp-content/uploads/sites/861/2024/03/Christian-Marsolais-Headshot-150x150.jpg)
Company: Theratechnologies Inc.
Job title: Senior Vice President & Chief Medical Officer
Seminars:
Targeting Sortilin (SORT1) to Unlock the Potential of Peptide Drug Conjugates (PDCs) in Oncology: Rapid Internalization Within Minutes with Unique Multimodal MOA and Safety Profile 10:00 am
Understand the rationale for targeting the SORT1 receptor in cancer Discuss the unique toxicity profile of sudocetaxel zendusortide (TH1902), the lead PDC from Theratechnologies’ SORT1+ Technology™ platform, that differs substantially from the safety profile of taxanes, due to the multimodal MOA of the conjugate and the low levels of free circulating docetaxel Discuss how this…Read more
day: Conference Day 1